Gemcitabine–oxaliplatin plus prednisolone is active in patients with castration-resistant prostate cancer for whom docetaxel-based chemotherapy failed

Bibliographic Details
Main Authors:	Lee, J-L, Ahn, J-H, Choi, M K, Kim, Y, Hong, S-W, Lee, K-H, Jeong, I-G, Song, C, Hong, B-S, Hong, J H, Ahn, H
Format:	Online
Language:	English
Published:	Nature Publishing Group 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021534/

Similar Items